Liquid Biopsy Market for Breast Cancer to See Robust Growth in the Coming Years | CAGR 19.2%
Breast Cancer Liquid Biopsy Market– Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Breast Cancer Liquid Biopsy Market. Some of the key players profiled in the study are Biocept, Inc., F. Hoffmann-La Roche Ltd. (Foundation Medicine, Inc.), Fluxion Biosciences, Inc., Menarini Group (Menarini Silicon Biosystems, Inc.), Myriad Genetics, Inc., NeoGenomics Laboratories, Inc., Qiagen N.V., Sysmex Corporation, and Thermo Fisher Scientific Inc. The global Breast Cancer Liquid Biopsy market is projected to reach $357.05 million by 2027, registering a CAGR of 19.2% from 2019 to 2027.
Click To get FREE SAMPLE PDF (Including Full TOC, Table & Figures): https://www.alliedmarketresearch.com/request-sample/7983
Breast Cancer Liquid Biopsy Market Outlook 2020-2030
The global market is divided into three categories, namely reagent kits, instruments, and services based on the product & service. The reagent kits segment was the market leader in 2019 and is expected to continue its dominance during the forecast period. The growth of the market is expected to be driven by the advent of new liquid biopsy reagents that allow circulating biomarker analysis and target enrichment, the approval of breast cancer liquid biopsy reagent kits, and the increase in funding for breast cancer liquid biopsy research and development. Additionally, other factors such as a surge in demand for reagent kits, an increase in the number of breast cancer liquid biopsy test procedures, and a rise in the prevalence of breast cancer worldwide are expected to contribute to the growth of the breast cancer liquid biopsy market.
The breast cancer liquid biopsy market is classified into three applications: diagnostics, prognostics, and risk assessment. In 2019, the diagnostics segment generated the highest market revenue and is expected to maintain its dominant position during the forecast period. The growth of the diagnostics segment is attributed to an increase in the number of breast cancer patients, a trend towards developing personalized therapeutics, technological advancements in liquid biopsy systems, and patient awareness towards safe and non-invasive liquid biopsy testing procedures.
Marketing Communication and Sales Channel
Understanding “marketing effectiveness” on a continual basis, help determine the potential of advertising and marketing communications and allow to use of best practices to utilize untapped audience. In order to make marketers make effective strategies and identify why the target market is not giving attention, we ensure the Study is Segmented with appropriate marketing & sales channels to identify potential market size by value & Volume* (if Applicable).
Have Any Query? Ask Our Expert @: https://www.alliedmarketresearch.com/purchase-enquiry/7983
The segments and sub-section of Breast Cancer Liquid Biopsy market is shown below:
By Product & Service: Reagent Kits, Instruments, and Services
By Circulating Biomarker: Circulating Tumor Cells, Extracellular Vesicles, and Circulating Tumor DNA
By Application: Diagnostics, Prognostics, and Risk Assessment
Some of the key players involved in the Market are: Biocept, Inc., F. Hoffmann-La Roche Ltd. (Foundation Medicine, Inc.), Fluxion Biosciences, Inc., Menarini Group (Menarini Silicon Biosystems, Inc.), Myriad Genetics, Inc., NeoGenomics Laboratories, Inc., Qiagen N.V., Sysmex Corporation, and Thermo Fisher Scientific Inc.
Important years considered in the Breast Cancer Liquid Biopsy study:
Historical year – 2017-2021; Base year – 2021; Forecast period** – 2022 to 2030 [** unless otherwise stated]
If opting for the Global version of Breast Cancer Liquid Biopsy Market; then below country analysis would be included:
– North America (USA, Canada and Mexico)
– Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe)
– Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC)
– South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Key Findings Of The Study
- The reagent kits segment was the largest in terms of market share in 2019 and is expected to maintain its dominant position throughout the forecast period.
- In terms of circulating biomarker, the circulating tumor cell segment held the largest market share in 2019 and is anticipated to continue its dominance throughout the forecast period.
- The diagnostics segment demonstrates the fastest growth and is projected to grow at a CAGR of 20.2% from 2019 to 2027.
- Asia-Pacific is expected to have the highest growth rate, with a CAGR of 20.7% during the forecast period, based on region.
Introduction about Breast Cancer Liquid Biopsy Market
Breast Cancer Liquid Biopsy Market Size (Sales) Market Share by Type (Product Category)
Breast Cancer Liquid Biopsy Market by Application/End Users
Breast Cancer Liquid Biopsy Sales (Volume) and Market Share Comparison by Applications
Global Breast Cancer Liquid Biopsy Sales and Growth Rate (2020-2030)
Breast Cancer Liquid Biopsy Competition by Players/Suppliers, Region, Type, and Application
Breast Cancer Liquid Biopsy (Volume, Value, and Sales Price) table defined for each geographic region defined.
Breast Cancer Liquid Biopsy Players/Suppliers Profiles and Sales Data
Key Raw Materials Analysis & Price Trends
Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis
……..and view more in complete table of Contents
Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/42933db94cea980c4cfc7f0c7365fffd
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
Read More Trending Reports Here:
Hydrogel Dressing Market by Product (Amorphous Hydrogel, Impregnated Hydrogel, and Sheet Hydrogel) and End user (Hospitals, Physician’s Office, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
Bioprocess Validation Market by Test Type (Extractables Testing Services, Microbiological Testing Services, Physiochemical Testing Services, Integrity Testing Services, Compatibility Testing Services, and Other Testing Services), Process Component (Filter Elements, Bioreactors, and Other Process Component), and End User (Pharmaceutical & Biotechnology Companies and Contract Development & Manufacturing Organizations): Global Opportunity Analysis and Industry Forecast, 2021-2030
Blockchain Technology in Healthcare Market By Type (Public, Private), By Application (Supply Chain Management, Data Exchange and Interoperability, Claims Adjudication and Billing, Others), By End User (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers): Global Opportunity Analysis and Industry Forecast, 2021-2030
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact Us:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
Editor Details
-
Company:
- The Wire Times
